Title |
Toll-Like Receptor Ligands Induce Expression of the Costimulatory Molecule CD155 on Antigen-Presenting Cells
|
---|---|
Published in |
PLOS ONE, January 2013
|
DOI | 10.1371/journal.pone.0054406 |
Pubmed ID | |
Authors |
Neha Kamran, Yoshimi Takai, Jun Miyoshi, Subhra K. Biswas, Justin S. B. Wong, Stephan Gasser |
Abstract |
Genotoxic stress and RAS induce the expression of CD155, a ligand for the immune receptors DNAM-1, CD96 and TIGIT. Here we show that antigen-presenting cells upregulate CD155 expression in response to Toll-like receptor activation. Induction of CD155 by Toll-like receptors depended on MYD88, TRIF and NF-κB. In addition, IRF3, but not IRF7, modulated CD155 upregulation in response to TLR3 signals. Immunization of CD155-deficient mice with OVA and the TLR9 agonist CpG resulted in increased OVA-specific IgG2a/c titers when compared to wild type mice. Splenocytes of immunized CD155-deficient mice secreted lower levels of IL-4 and fewer IL-4 and GATA-3 expressing CD4(+) T cells were present in the spleen of Cd155(-/-) mice. Our data suggest that CD155 regulates T(h)2 differentiation. Targeting of CD155 in immunization protocols using peptides may represent a promising new approach to boost protective humoral immunity in viral vaccines. |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
United Kingdom | 1 | <1% |
United States | 1 | <1% |
Germany | 1 | <1% |
Switzerland | 1 | <1% |
Unknown | 100 | 96% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Researcher | 28 | 27% |
Student > Ph. D. Student | 25 | 24% |
Student > Bachelor | 11 | 11% |
Other | 7 | 7% |
Student > Master | 6 | 6% |
Other | 15 | 14% |
Unknown | 12 | 12% |
Readers by discipline | Count | As % |
---|---|---|
Agricultural and Biological Sciences | 43 | 41% |
Immunology and Microbiology | 25 | 24% |
Medicine and Dentistry | 8 | 8% |
Biochemistry, Genetics and Molecular Biology | 7 | 7% |
Pharmacology, Toxicology and Pharmaceutical Science | 1 | <1% |
Other | 2 | 2% |
Unknown | 18 | 17% |